|
Nutrition Research Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA, IHS, OS
|
NIDDK, CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ODP, OD/DPCPSI/ODS
|
The Nutrition Research Coordinating Committee (NRCC) was established by the National Institutes of Health (NIH) Office of the Director in 1975 to improve communication and research coordination of nutrition activities within the NIH and across the federal government. Today it provides an open forum for members to discuss current and future nutrition research challenges and opportunities. The NRCC has broad representation from the NIH institutes and centers. In addition, liaisons from other federal offices and agencies also participate. The NRCC meets monthly, alternating between intra-NIH and interagency meetings. NRCC membership is open to any federal staff member interested in carrying out any trans-NIH or trans-agency nutrition research efforts. NRCC meetings are chaired by the Director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Office of Nutrition Research.
|
|
Obesity Prevention and Control: Combined School-Based Interventions to Increase Healthier Food and Beverage Consumption and Physical Activity
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
Ongoing participation on monthly calls by the Community Guide Coordinating Team.
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
This is a study of the safety, adherence, and efficacy of a fixed-dose combination of drug tenofovir/lamivudine/dolutegravir (TLD) among HIV patients, including those co-infected with tuberculosis, receiving care at PEPFAR (President’s Emergency Plan for AIDS Relief) funded sites in resource limited countries.
|
|
Office for Human Research Protections/Office of Extramural Research Training Initiative
|
Meeting/ Workshop
|
OS
|
OD/OER
|
The National Institutes of Health (NIH) collaborated with the Office for Human Research Protections to provide comprehensive training at both NIH Regional Meetings for the extramural community.
|
|
Office of Justice Programs/HHS Medicolegal Death Investigation Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID, CC, NICHD
|
Identify short and long term goals to develop and implement programmatic activities that support the Medicolegal Death Investigation system.
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS, FDA, OSG
|
NIBIB, NCI
|
The purpose of this working group is to coordinate the efforts of multiple stakeholders (Department of State, Department of Energy, Department of Homeland Security, Department of Health and Human Services, private sector) to establish a stable, long-term domestic supply of Mo99 (molybdenum-99) for medical purposes. Such a supply needs to be consistent with current international goals (to which the US is an active participant) of reduction in the use of high-enriched uranium in all reactors, including Mo99 production facilities, as well as full cost recovery solutions. The National Institutes of Health (NIH) staff attend stakeholders workshops, the last was held in the Spring of 2018.
|
|
Office of Secretary, Patient-Centered Outcomes Research Trust Fund (OS-PCORTF) PCORTF Projects titled, “Data Capacity for PCOR through eCare Planning for People with Multiple Chronic Conditions & Disability.”
|
Other
|
ACL, AHRQ, IHS
|
NHLBI, NCI, NIA, NIDDK, NLM
|
This project aims to improve the accessibility of patient-centered data for research and care by developing an accessible, interoperable, person-centered electronic (e)care plan.
|
|
Overcoming Waning Immunity in Pertussis Vaccines
|
Meeting/ Workshop
|
OS
|
NIAID
|
The meeting aims to identify research and knowledge gaps and strategies to overcome waning immunity of acellular pertussis vaccines
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
At the Food and Drug Administration (FDA), Dr. Weinberg is transducing murine keratinocytes with combinations of oncogenes found in human squamous cell carcinomas to determine if they generate transformation and tumors in laboratory conditions. Dr. Van Waes’ laboratory at the National Institute on Deafness and Other Communication Disorders (NIDCD) will study how these oncogene-driven tumors in mice deregulate keratinocytes and host immune responses, as well as response to various standard, molecular, and immune therapies.
|
|
Partners in Information Access for the Public Health Workforce
|
Resource Development
|
AHRQ, CDC, HRSA, OS
|
NLM
|
Partners in Information Access for the Public Health Workforce is a collaboration of US government agencies, public health organizations, and health sciences libraries that provides timely, convenient access to selected public health resources on the Internet.
|